IBMS/ECTS 2001 - PROGRAM and ABSTRACTS
POSTMENOPAUSAL OSTEOPOROSIS:
CLINICAL PATHWAYS OF THE FUTURE
Sponsored by Eli Lilly and Company
Chairs: Pierre Meunier (Lyon, France),
Jean-Yves Reginster (Liège, Belgium)
Friday, June 8, 2001
17:30 - 19:30 Auditorium
PTH: PAST, PRESENT, AND FUTURE
John T. Potts
Distinguished Jackson Professor of Clinical Medicine, Harvard Medical School
Director of Research, Massachusetts General Hospital, Charlestown, Massachusetts, USATHE EFFECTS OF PTH ON FRACTURE REDUCTION
Pierre D. Delmas
Professor of Medicine, University Claude Bernard of Lyon, Director INSERM Unit 403, Hôpital Edouard Herriot, Lyon, FranceTHE UNIQUE PROFILE OF SERMs
Adolfo Diez-Perez
Professor of Medicine, Autonomous University of Barcelona, Head of Department of Internal Medicine, Hospital del Mar and Municipal Institute of Medical Research, Barcelona, SpainCLINICAL MANAGEMENT OF POSTMENOPAUSAL OSTEOPOROSIS
Robert Lindsay
Professor of Clinical Medicine, Columbia University College of Physicians and Surgeons, New York, New York, USA
Chief, Internal Medicine Director, Clinical Research Center, Helen Hayes Hospital West Haverstraw, New York, USA